This study evaluated whether IKZF1 and/or BTG1 silencing could impact the cell viability and transcript levels of glucocorticoid-responsive genes compared to dexamethasone treatment using the B-ALL 207 cell line as the experimental model. The gene discussed is BTG1; the disease is acute lymphoblastic leukemia.